Search results for " growth" in Articles / App Notes
Article
Scaling Up Novel Therapies
The reactors are designed so that a very large surface for cell growth is packed inside a small volume, reducing the number and complexity of operations compared with traditional equipment, he says. T…
Article
Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs
Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs
Analytical exoglycosidases are transitioning from being largely academic tools to being s…
Article
A Look into the Future of Biopharmaceutical Quality
A Look into the Future of Biopharmaceutical Quality
Quality experts share insights on what the future may hold regarding regulatory quality requirements for biopharmaceuticals.
…
Article
Biopharma Seeks Balance
The ups and downs of investment cycles play a major role in industry health and growth, and broad economic market forces, shifts in legislative and regulatory policy, and investor appetite for risk im…
Article
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
And much of the current growth in capacity involves single-use adoption at commercial scales.
Geographically, 15 years ago, the industry did not predict the rise in bioprocessing in developing …
Article
Development and Future of Protein A Chromatography Technology: Q&A with Jonathan Royce, Business Leader Chromatography Resins, Cytiva
However, although mAbs is still the biggest application area and has significant growth, the early clinical pipeline is full of a diversity of different antibody related molecules. Many of them can st…
Article
Bioburden Control in the Biopharmaceutical Industry
Walker, “Innovation at the Heart of Biopharmaceutical Industry Growth,” www.americanpharmaceuticalreview.com/Featured-Articles/187354-Innovation-at-the-Heart-of-Biopharmaceutical-Industry-Growth, acce…
Article
The New World of Biopharmaceutical Manufacturing
Single-use systems must be tested extensively to ensure that their materials of construction do not inhibit cell growth or release chemicals into the product stream during bioprocessing. Biomanufactur…
Article
From Darwin to Recombinant Fc Multimers
The expected growth from 2017-2020 is expected to be 6-8%, reaching a business size of $20 billion. IgG market will continue to dominate with 46% of market, followed by albumin, 18%, John Perkins stre…
Article
Unifying Continuous Biomanufacturing Operations
Through continuous manufacturing methods upstream, engineers have been mastering the ways to support the growth of cells to desired volumes while preserving cell viability. Downstream continuous purif…